Effect of inclisiran on lipids in primary prevention: the ORION-11 trial

AbstractAims. Patients often require combination therapies to achieve LDL cholesterol (LDL-C) targets for the primary prevention of atherosclerotic cardiovascul

Read the full article here

Related Articles